Published September 2014 | Version v1
Journal article

Preliminary thermoluminescence and optically stimulated luminescence investigation of commercial pharmaceutical preparations towards the drug sterilization dosimetry

  • 1. Department of Archaeometry and Physicochemical Measurements, R.C. 'Athena', PO Box 159, Kimmeria University Campus, 67100 Xanthi (Greece)
  • 2. Nuclear Physics Laboratory, Physics Department, Aristotle University of Thessaloniki, 54124 Thessaloniki (Greece)

Description

Drug sterilization with ionizing radiation is a well-established technology and is gaining ground the last decades due to its numerous advantages. Identification of irradiated drugs would be interesting and, in this respect, the present work aims, for the first time to the authors’ best knowledge, to explore whether OSL and TL can be employed as methods for post-sterilization dosimetry on commercial drugs, i.e., as tools for the detection of irradiated drugs. Five widely used drugs, i.e., Daktarin®, Aspirin®, Panadol®, Brufen® and Procef®, are used for this purpose. Preliminary findings are very promising towards the post-sterilization dosimetry and the use of commercial drugs for normal and/or accidental dosimetry. - Highlights: • A study of the potential use of certain drugs in post-sterilization dosimetry with TL and OSL is conducted. • All investigated drugs exhibit detectable OSL and TL signals in a dose range of 20–1400 Gy. • Presence of slow components in the OSL signals is probable. • Dose response data can be fitted with a second order polynomial or a power function. • Preliminary results are promising and a more thorough study is imperative

Availability note (English)

Available from http://dx.doi.org/10.1016/j.apradiso.2014.05.012

Additional details

Identifiers

DOI
10.1016/j.apradiso.2014.05.012;
PII
S0969-8043(14)00206-1;

Publishing Information

Journal Title
Applied Radiation and Isotopes
Journal Volume
91
Journal Issue
Complete
Journal Page Range
p. 79-91
ISSN
0969-8043
CODEN
ARISEF

Optional Information

Copyright
Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.